本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioCryst制药

8.55
0.0000
盘后8.550.0021+0.02%18:41 EDT
成交量:236.41万
成交额:2,024.91万
市值:17.89亿
市盈率:-32.95
高:8.64
开:8.53
低:8.50
收:8.55
数据加载中...
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/22

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/12/21

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/07

重要事件披露

8-K - Current report